; (B) by striking 1.8% and inserting 2.4% ; and (C) by striking 12/31/2020 and inserting 12/31/2025 . (38) Clothianidin Heading 9902.07.06 is amended— (A) by amending the article description to read as follows: (E)-1-(2-Chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitro- guanidine (Clothianidin) (CAS No. 210880–92–5) (provided for in subheading 2934.10.90) ; (B) by striking 6.1% and inserting 5.9% ; and (C) by striking 12/31/2020 and inserting 12/31/2025 . (39) Thiamethoxam Heading 9902.07.07 is amended— (A) by amending the article description to read as follows: Thiamethoxam (3-(2-chloro-5-thiazolylmethyl)tetrahydro-5- methyl-N-nitro-1,3,5-oxadiazin-4-imine) (CAS No. 153719–23–4) (provided for in subheading 2934.10.90) ; (B) by striking 2.5% and inserting 6% ; and (C) by striking 12/31/2020 and inserting 12/31/2025 . (40) Difenoconazole Heading 9902.07.14 is amended— (A) by amending the article description to read as follows: 1-({2-[2-Chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3- dioxolan-2-yl}methyl)-1H-1,2,4-triazole (Difenoconazole) (CAS No. 119446–68–3) (provided for in subheading 2934.99.12) ; (B) by striking 4.6% and inserting 5.6% ; and (C) by striking 12/31/2020 and inserting 12/31/2025 . (41) Fluoxastrobin Heading 9902.07.21 is amended— (A) by amending the article description to read as follows: (E)-1-[2-[6-(2-Chlorophenoxy)-5-fluoropyrimidin-4-yl]oxyphenyl]-1-(5,6-dihydro-1,4,2-dioxazin-3-yl)-N-methoxymethanimine (Fluoxastrobin) (CAS No. 361377–29–9) (provided for in subheading 2934.99.12) ; (B) by striking Free and inserting 2.7% ; and (C) by striking 12/31/2020 and inserting 12/31/2025 . (42) Isoxaflutole Heading 9902.07.22 is amended— (A) by amending the article description to read as follows: (5-Cyclopropyl-1,2-oxazol-4-yl)-[2-methylsulfonyl-4-(trifluoromethyl)phenyl]methanone (Isoxaflutole) (CAS No. 141112–29–0) (provided for in subheading 2934.99.15) ; (B) by striking 5.5% and inserting 4.8%